Enzo Biochem Releases New Investor Presentation on Corporate Strategy
November 25, 2015
Enzo Biochem, Inc. (NYSE:ENZ) today released a new investor presentation that, in light of recently announced approval for the Company’s HCV viral load testing by the New York State Department of... Read More
Enzo Biochem Announces New York State Approval of Its First Assay Based on AmpiProbeTM Platform Aimed at Providing Affordable Molecular Diagnostics in Light of Reimbursement Pressure
November 17, 2015
Enzo Biochem, Inc. (NYSE:ENZ) today announced that the New York State Department of Health has granted approval of Enzo Clinical Labs’ AmpiProbe-HCV ™ assay for the quantitative detection of Hepatitis... Read More
Enzo Biochem Demonstrates Greater Sensitivity of Its AmpiProbe™ Platform for Molecular Diagnostics
October 29, 2015
Enzo Biochem, Inc. (NYSE: ENZ) today announced it had demonstrated new thresholds of sensitivity and breadth for its assay for the measurement of Hepatitis C virus (HCV) viral load. The data was... Read More
New Tech Partnership Aims for Faster Rape Kit Processing
October 20, 2015
category Publishing & Media
Enzo Biochem Reaches $10 Million Patent Infringement Settlement with Affymetrix, Inc.
October 13, 2015
Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has reached and finalized a settlement with Affymetrix, Inc. (NASDAQ:AFFX) involving payment of $10 million to Enzo in an infringement action... Read More
Enzo Biochem Reports Strong Fourth Quarter Results
October 13, 2015
Enzo Biochem Inc. (NYSE:ENZ) today reported results for the fiscal quarter and year ended July 31, 2015. Read More
Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Full Year Results Tuesday, October 13, 2015 at 8:30 AM E.T.
October 07, 2015
Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2015 fourth quarter and full year results, Tuesday, October 13, 2015, at 8:30 AM E.T. Read More
Enzo Biochem Reaches $7.1 Million Patent Infringement Settlement with Luminex Corporation
July 06, 2015
Enzo Biochem Reports Third Quarter Results, Including Strong Revenue Growth at Clinical Labs Reflecting Increasing Volume and Greater Molecular Diagnostic Activity
June 09, 2015
Enzo Biochem Schedules Teleconference to Discuss Third Quarter Results Wednesday, June 10, 2015 at 8:30 AM E.T.
June 04, 2015
How it All Plays Out: Complementary Research on China Cord Blood, Biolase, Cara Therapeutics, Tonix, and Enzo Biochem
April 24, 2015
from PR Newswire
Enzo Biochem Announces New York State Approval of First FlowScript™ Assay for Improved Detection of Cervical Cancer Progression
March 13, 2015
Enzo Biochem Reports Fiscal Second Quarter Results
March 12, 2015
Enzo Biochem Schedules Teleconference to Discuss Second Quarter Results Friday, March 13, 2015 at 8:30 AM E.T.
March 09, 2015
Enzo Biochem Announces New Molecular Platform and First Product for Early Focus on Cervical Cancer Progression
February 10, 2015
Enzo Biochem Reports Strong Fiscal First Quarter Results
December 09, 2014
Enzo Biochem Schedules Teleconference to Discuss First Quarter Results Wednesday, December 10, 2014 at 8:30 AM E.T.
December 03, 2014
Enzo Biochem Reports Strong Fiscal Fourth Quarter Results
October 09, 2014
Enzo Biochem Awarded Patent for Novel Vectors Involving Gene Therapy Treatments for Cancer, Virus Infections and Genetic Diseases
October 07, 2014
Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter Results Friday, October 10, 2014 at 8:30 AM E.T.
October 06, 2014
Thomas C Wright, MD, World Recognized Women’s Health Sciences Authority, Joins Enzo Biochem’s Clinical Division
July 31, 2014
Enzo Biochem Announces August 18, 2014 as Date of Markman Hearing in Patent Infringement Lawsuit Against Leading Life Sciences Companies
July 29, 2014
New Drug Applications, Agreements, Launches, and Appointments - Analyst Notes on Curis, Enzo Biochem, AGTC, Halozyme and Magellan Health
July 02, 2014
from PR Newswire
Enzo Biochem Reports Strong Third Fiscal Quarter Results
June 09, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here